(480) 923-0802
Join Our Panel
Consulting
Insights
Podcast
DVI
About
Contact Us
Posts Tagged ‘drug
All Categories
Our Take Newsletter
Downloadable Articles
By the Numbers
October 28, 2019
Our Take: Biogen’s aducanumab gets a second life
Read More
September 09, 2019
Our Take: Judge rules against Johnson & Johnson in landmark opioid case
Read More
August 12, 2019
Our Take: FDA threatens legal action against Novartis over faulty data used in application for $2.1 million gene therapy
Read More
August 12, 2019
Episode 65: Our Take, August 12, 2019
Read More
August 05, 2019
Our Take: CMS gears up for fiscal year 2020
Read More
July 29, 2019
Episode 63: Our Take, July 29, 2019
Read More
June 17, 2019
Episode 55: Our Take, June 17, 2019
Read More
June 13, 2019
Episode 54: Building an in-house specialty pharmacy within an IDN with Brett McClain
Read More
June 10, 2019
Episode 53: Our Take, June 10, 2019
Read More
June 03, 2019
Our Take: Novartis sets $2.1M price for spinal muscular atrophy gene therapy, watchdog agrees
Read More
May 30, 2019
Episode 51: Three Dartmouth Guys Talk Health Care
Read More
May 23, 2019
Episode 50: Our Take May–Part 2
Read More
February 19, 2019
Our Take: FDA panels recommend approval for novel depression treatment
Read More
December 10, 2018
Our Take: CVS’ new PBM model focuses on net cost pricing for greater predictability
Read More
Posts navigation
Previous
1
…
16
17
18
Next
Sign up for Our Take
the weekly strategic brief for Health Care Executives
Please leave this field empty
First name
*
Last name
*
Email
*
Company
*
Job Title
*
Thank you for signing up! Check your inbox or spam folder to confirm your subscription.
share
Consulting
Insights
Podcast
DVI
About
Contact Us